BioMarin Pharmaceutical Inc.
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionUtah Retirement Systems
Latest Disclosed Ownership31,178 shares
Latest Disclosed Value $ 1,761,245
Utah Retirement Systems ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Utah Retirement Systems filed a 13F-HR form disclosing ownership of 31,178 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $1,761,245 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 31,178 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 0 0.00 1,761 -4.91 0.0180
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 0 0.00 1,853 9.72 0.0176
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 0 0.00 1,689 -1.46 0.0164
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 0 0.00 1,714 -22.24 0.0179
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 0 0.00 2,204 7.52 0.0254
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 0 0.00 2,049 -6.48 0.0226
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 0 0.00 2,192 -14.61 0.0247
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,178 -1,100 -3.41 2,567 -8.97 0.0305
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,278 -100 -0.31 2,819 -9.68 0.0330
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,378 200 0.62 3,122 9.62 0.0398
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,178 200 0.63 2,847 2.74 0.0407
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,978 -900 -2.74 2,772 -13.32 0.0384
2023-05-16 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,878 100 0.31 3,197 -5.75 0.0462
2023-02-15 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,778 -300 -0.91 3,392 20.97 0.0538
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,078 500 1.53 2,804 3.85 0.0468
2022-08-16 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,578 0 0.00 2,700 7.48 0.0432
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,578 -500 -1.51 2,512 -14.03 0.0334
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,078 100 0.30 2,922 14.63 0.0361
2021-11-16 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,978 -1,800 -5.18 2,549 -12.16 0.0345
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,778 100 0.29 2,902 10.81 0.0374
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,678 -1,500 -4.15 2,619 -17.43 0.0365
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 36,178 1,500 4.33 3,172 20.24 0.0450
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,678 300 0.87 2,638 -37.78 0.0438
2020-08-13 2020-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 34,378 300 0.88 4,240 47.22 0.0778
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,378 300 4,240 77,821.1545
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,078 0 0.00 2,880 -0.03 0.0623
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,078 100 0.29 2,881 25.75 0.0506
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,978 300 0.89 2,291 -20.59 0.0436
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,678 321 0.96 2,885 -2.63 0.0553
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,357 476 1.45 2,963 5.82 0.0587
2019-02-08 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,881 100 0.31 2,800 -11.92 0.0633
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,781 200 0.61 3,179 3.58 0.0616
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,581 100 0.31 3,069 16.56 0.0635
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,481 100 0.31 2,633 -8.80 0.0560
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,381 400 1.25 2,887 -2.99 0.0607
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,981 100 0.31 2,976 2.76 0.0669
2017-08-08 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,881 700 2.24 2,896 5.81 0.0675
2017-05-11 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,181 0 0.00 2,737 5.96 0.0655
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,181 0 0.00 2,583 -10.47 0.0650
2016-11-07 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,181 1,500 5.05 2,885 24.95 0.0747
2016-08-03 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,681 800 2.77 2,309 -3.06 0.0615
2016-05-10 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,881 100 0.35 2,382 -21.02 0.0646
2016-02-11 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,781 100 0.35 3,016 -0.17 0.0818
2015-11-03 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,681 100 0.35 3,021 -22.72 0.0865
2015-08-11 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,581 500 1.78 3,909 11.72 0.1039
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,081 2,900 11.52 3,499 53.73 0.0919
2015-02-11 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,181 0 0.00 2,276 25.26 0.0626
2014-11-06 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,181 -100 -0.40 1,817 15.51 0.0521
2014-08-08 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,281 300 1.20 1,573 -7.69 0.0451
2014-05-08 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,981 200 0.81 1,704 -2.13 0.0491
2014-02-05 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,781 0 0.00 1,741 -2.74 0.0515
2013-11-06 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,781 -200 -0.80 1,790 28.41 0.0579
2013-08-02 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,981 24,981 1,394 0.0471
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.